Scholar Rock (NASDAQ:SRRK) Stock Crosses Above 200-Day Moving Average – Here’s Why

Scholar Rock Holding Corporation (NASDAQ:SRRK) shares crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $48.22 and traded as high as $51.76. Scholar Rock shares last traded at $51.55, with a volume of 2,795,181 shares.

Key Scholar Rock News

These are some of the SRRK news items that stood out recently:

• Positive Sentiment: For Q3 2026, Scholar Rock reported a loss of $0.81 per share, beating analyst estimates of a $0.85 loss; revenue of $0.57 million also exceeded the $0.30 million estimate. The loss narrowed from $0.90 per share a year earlier. Zacks earnings report
• Positive Sentiment: The quarter marked Scholar Rock’s first product revenue, an early sign of commercialization of ISEMBYLD. The initial revenue base was modest, so investors may look for evidence of a stronger launch ramp. First product revenue report
• Positive Sentiment: HC Wainwright maintained a Buy rating and a $70 price target. Its 2027 quarterly loss estimates narrow from $0.76 per share in Q1 to $0.55 in Q4, though losses are still projected. Analyst estimates

Analyst Ratings Changes

SRRK has been the topic of several recent research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Scholar Rock in a report on Thursday, October 15th. Raymond James Financial reiterated a “strong-buy” rating on shares of Scholar Rock in a research report on Tuesday. Truist Financial raised their price objective on shares of Scholar Rock from $76.00 to $77.00 and gave the stock a “buy” rating in a research note on Thursday, September 24th. Jefferies Financial Group lifted their price objective on Scholar Rock from $57.00 to $65.00 and gave the stock a “buy” rating in a research report on Monday, September 14th. Finally, Piper Sandler lifted their price objective on Scholar Rock from $60.00 to $75.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 15th. Four investment analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Scholar Rock has an average rating of “Moderate Buy” and a consensus price target of $67.67.

Scholar Rock Trading Down 2.9%

The business has a 50-day moving average of $46.64 and a 200 day moving average of $48.23. The stock has a market cap of $5.68 billion, a PE ratio of -13.87 and a beta of 0.78. The company has a debt-to-equity ratio of 0.77, a quick ratio of 7.02 and a current ratio of 7.02.

Scholar Rock (NASDAQ:SRRK) last released its earnings results on Tuesday, November 10th. The company reported ($0.81) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.85) by $0.04. The firm had revenue of $0.57 million during the quarter, compared to analysts’ expectations of $0.30 million. During the same quarter last year, the company posted ($0.90) earnings per share. Equities research analysts predict that Scholar Rock Holding Corporation will post -3.29 EPS for the current fiscal year.

Insider Buying and Selling at Scholar Rock

In other news, Director Srinivas Akkaraju acquired 146,970 shares of Scholar Rock stock in a transaction that occurred on Monday, October 26th. The shares were acquired at an average price of $41.59 per share, with a total value of $6,112,482.30. Following the completion of the purchase, the director owned 6,380,517 shares of the company’s stock, valued at approximately $265,365,702.03. This represents a 2.36% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 10.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of SRRK. GW&K Investment Management LLC purchased a new position in shares of Scholar Rock during the 3rd quarter worth $17,534,000. Voya Investment Management LLC boosted its holdings in shares of Scholar Rock by 4.8% during the third quarter. Voya Investment Management LLC now owns 933,359 shares of the company’s stock worth $45,100,000 after purchasing an additional 42,752 shares during the last quarter. Public Sector Pension Investment Board purchased a new stake in shares of Scholar Rock in the third quarter valued at $3,044,000. Russell Investments Group Ltd. grew its position in shares of Scholar Rock by 7.5% in the third quarter. Russell Investments Group Ltd. now owns 140,270 shares of the company’s stock valued at $6,778,000 after purchasing an additional 9,756 shares during the period. Finally, Nan Fung Trinity HK Ltd. grew its position in shares of Scholar Rock by 164.9% in the third quarter. Nan Fung Trinity HK Ltd. now owns 264,695 shares of the company’s stock valued at $12,790,000 after purchasing an additional 164,776 shares during the period. 91.08% of the stock is currently owned by institutional investors and hedge funds.

Scholar Rock Company Profile

Scholar Rock is a biopharmaceutical company based in Cambridge, Massachusetts, that develops medicines targeting growth factors and signaling proteins involved in disease. Its research has focused on the transforming growth factor beta (TGF-?) superfamily, which plays roles in processes including muscle development and immune regulation. The company’s lead program has been apitegromab, a selective inhibitor of myostatin developed for spinal muscular atrophy (SMA). Scholar Rock has studied the medicine as a potential treatment alongside existing SMA therapies, with the goal of improving patients’ motor function.